6 Recruiting Fabry Disease Phase 3 Clinical Trials
Active phase 3 studies for fabry disease enrolling across the USA. Verify eligibility and contact site coordinators.
All Fabry Disease studiesPhase 3 Studies for Fabry Disease
🔵 Active, Not Recruiting Phase3
A Study to Evaluate the Effect of Venglustat Tablets on Neuropathic and Abdominal Pain in Male and Female Participants ≥16 Years of Age With Fabry Disease
📍 Nephrology Clinic at Kirklin Clinic of UAB Hospital_Investigational Site Number: 8400011 — Birmingham, Alabama
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase3
A Study to Evaluate the Long-term Safety and Tolerability of Lucerastat in Adult Subjects With Fabry Disease
📍 University of Alabama at Birmingham - Nephrology Research Clinic — Birmingham, Alabama
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase3
A Study to Evaluate the Effect of Venglustat Tablets on Left Ventricular Mass Index in Male and Female Adult Participants With Fabry Disease
📍 University of Alabama -The Kirklin Clinic- Site Number : 8400010 — Birmingham, Alabama
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase3
A Study to Evaluate Migalastat in Fabry Subjects With Amenable GLA Variant and Renal Disease
📍 Emory University — Atlanta, Georgia
View Study & Checklist ➔ 🟢 Recruiting Phase3
A Study of Migalastat in Pediatric Subjects (2 to <12 Yrs) With Fabry Disease and Amenable GLA Variants
📍 Emory Genetics — Atlanta, Georgia
View Study & Checklist ➔ 🟢 Recruiting Phase2 / Phase3
A Study to Learn About the Safety and Effects of the Study Drug PRX-102 in Children and Adolescents With Fabry Disease
📍 Phoenix Children's — Phoenix, Arizona
View Study & Checklist ➔